These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 12806956)

  • 1. [Economic analysis of adverse events in cancer treatment].
    Koinuma N; Takeyoshi H
    Nihon Rinsho; 2003 Jun; 61(6):1030-8. PubMed ID: 12806956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of cancer therapies: more and better studies will lead to better choices in cancer care.
    Uyl-de Groot CA
    Eur J Cancer; 2006 Nov; 42(17):2862-6. PubMed ID: 17008095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological issues in the economic analysis of cancer treatments.
    Tappenden P; Chilcott J; Ward S; Eggington S; Hind D; Hummel S
    Eur J Cancer; 2006 Nov; 42(17):2867-75. PubMed ID: 17023160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
    Rizzo JD
    Best Pract Res Clin Haematol; 2005; 18(3):439-48. PubMed ID: 15792918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpreting the economic literature in oncology.
    Grusenmeyer PA; Wong YN
    J Clin Oncol; 2007 Jan; 25(2):196-202. PubMed ID: 17210940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methodology of economic assessment: example in oncology].
    Jaisson-Hot I; Schott AM; Clippe C; Ganne C; Hajri T; Poncet B; Trillet-Lenoir V; Colin C
    Bull Cancer; 2003 Nov; 90(11):939-45. PubMed ID: 14706896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cancer in adolescents and young adults: is affordability a concern?
    Gafni A
    Cancer; 2011 May; 117(10 Suppl):2258-61. PubMed ID: 21523743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medico-economical assessment in cancerology].
    Lebrun T; Selke B; Bercez C; Bonneterre ME; Lenne X; Sailly JC; Bonneterre J
    Bull Cancer; 1997 May; 84(5):543-6. PubMed ID: 9295860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic and cost-effectiveness issues in breast cancer treatment.
    Hillner BE
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):98-104. PubMed ID: 8614853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer and health economics].
    Koinuma N
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):1-7. PubMed ID: 8546457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis for clinical procedures in oncology.
    Weinstein MC
    Bull Cancer; 1980; 67(5):491-500. PubMed ID: 6783150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses.
    Carlson LE; Bultz BD
    Psychooncology; 2004 Dec; 13(12):837-49; discussion 850-6. PubMed ID: 15578622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of treatments for cancer in childhood.
    Barr RD; Feeny D; Furlong W
    Eur J Cancer; 2004 Jun; 40(9):1335-45. PubMed ID: 15177493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of high-cost cancer care: a behavioral science perspective.
    Weinfurt KP
    J Clin Oncol; 2007 Jan; 25(2):223-7. PubMed ID: 17210944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomics of amifostine in ovarian cancer.
    Calhoun EA; Bennett CL
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):102-7. PubMed ID: 10348268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of oral valdecoxib versus diclofenac in the treatment of patients with rheumatoid arthritis in a randomized clinical trial.
    von Scheele B; Peña B; Wong J; Niculescu L
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii53-9. PubMed ID: 14585918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.